Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...
The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...
And it's not chewing tobacco, because there's no tobacco or spitting required. It's called Zyn, a brand of nicotine pouches that have gained popularity, especially among younger demographics.
The Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment. The ...
Federal health officials authorize Zyn nicotine pouches, citing potential to help adult smokers cut back or quit WASHINGTON -- Federal health officials authorize Zyn nicotine pouches, citing ...
FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food and Drug ...
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...